ACGT DNA Technologies Corporation announced that further to its announcement on July 24, 2020, about the joint development agreement entered into with ITOCO Inc., an Oakville Ontario resident company, that ITOCO has failed to make two key milestone payments as required under the agreement. Under the agreement, the parties had agreed to co-develop and market ACGT's molecular diagnostic technology which includes a one-step DNA test kit and a patented diagnostic instrument. The Joint Project was expected to span a twenty-four month period. Without the milestone payments the Joint Project is unable to go forward. Under the agreement, ITOCO had also agreed to fund a new laboratory in Ontario for the purposes of further research into related technology. This funding has also not been provided. ACGT has given written termination notice to ITOCO under the terms of the agreement.